Medicare's new powers to control drug prices to face lobbying ...

Medicare's new powers to control drug prices to face lobbying ... - NPR

The Inflation Reduction Act gives Medicare historic new powers to limit prescription drug prices. But the pharmaceutical industry is already ...

Future of Medicare drug price negotiations murky under Trump

GOP lawmakers have likened the new drug negotiation law to "government price controls" reducing drug companies' research into new drugs.

Biden admin announces results of historic Medicare drug price ...

Medicare's new power to negotiate drug prices will lead to an estimated $6 billion in savings for the federal government and a $1.5 billion reduction in out-of ...

Medicare drug price cuts could have limited early impact, but grow ...

The IRA's impact on drug prices could grow in the coming years. The act will subject 15 medicines to Medicare price negotiations in 2027 and ...

Medicare Drug Price Negotiation Program - CMS

In August 2022, President Biden signed the Inflation Reduction Act of 2022 (P.L. 117-169) into law. The law makes improvements to Medicare ...

Biden administration strikes deal to cut prices on some of Medicare's ...

Medicare reached agreements with major pharmaceutical companies to cut the cost the government pays for ten prescription drugs used by ...

Passage of Inflation Reduction Act gives Medicare historic new powers

Medicare is gaining the power to negotiate prices for certain drugs and punish pharmaceutical companies that don't play by the rules.

In a huge victory for Dems, Medicare poised to negotiate drug prices

President Biden is on the verge of his own crowning health care achievement to call, in his words, a BFD: Medicare negotiating drug prices.

Big Drug Companies Are in Court to Stop Medicare Negotiation and ...

These lawsuits seek to end Medicare's new ability to negotiate lower prescription drug prices for Medicare beneficiaries.

Medicare announces plan to recoup billions from drug companies

Drugmakers will be required to pay Medicare back for price increases that outpace inflation. The industry is expected to put up a fight over ...

Drug prices: Drugmakers aim to fight Medicare negotiations ... - CNBC

Merck, the U.S. Chamber of Commerce and Bristol Myers Squibb have sued the Biden administration over Medicare's new drug-price negotiations.

FAQs about the Inflation Reduction Act's Medicare Drug Price ... - KFF

The Centers for Medicare & Medicaid Services (CMS) recently concluded the first round of negotiation for the new Medicare Drug Price Negotiation Program, ...

What to know about Medicare drug price negotiation

Allowing CMS to negotiate drug prices on behalf of its beneficiaries and private plan enrollees would help reduce out-of-pocket spending.

Medicare names first 10 drugs up for price negotiation ... - NBC News

Medicare announced the first 10 prescription drugs that will be subject to price negotiation to lower drug costs.

U.S. Announces First Drugs Picked for Medicare Price Negotiations

The price negotiation program, established by Democrats as part of the Inflation Reduction Act, is projected to save the government tens of ...

How Big Pharma is fighting a Biden program to lower seniors' drug ...

Drug companies have tried to invalidate a program that would reduce the price of medications for high blood pressure, heart disease, ...

A Political History of Medicare and Prescription Drug Coverage - PMC

In fact, members of Congress from both parties contended that some seniors struggling to pay for prescription drugs may actually end up worse off than they are ...

Despite record federal lobbying spending, the pharmaceutical and ...

Industry lobbyists tackle government attempts to lower drug prices, among other legislative and regulatory efforts, maintaining the ...

Klobuchar, Welch, Colleagues Introduce Legislation to Boost ...

Provisions from Klobuchar's bill to empower Medicare to negotiate prescription drug prices were signed into law last year.

WATCH: Biden and Harris announce deal to cut Medicare prices of ...

The Biden administration inked deals with pharmaceutical companies to knock down the lists prices for 10 of Medicare's costliest drugs.